GBP/USD Current price: 1.3737

  • The UK Markit Construction PMI jumped to 61.7 in March.
  • Concerns related to the AstraZeneca covid vaccine weigh on the pound.
  • GBP/USD remains under selling pressure and is poised to extend its slump.

The British Pound remained among the worst performers against the greenback, as the GBP/USD pair extended its weekly decline to 1.3718, ending the day around 1.3740. UK macroeconomic data was quite encouraging, as the March Markit Construction PMI hit 61.7, improving from 53.3 and largely surpassing the expected 54.6. Concerns surrounding the AstraZeneca vaccine keep weighing on sterling, as the EMA found a “rare link” between the jab and blood clots. Nevertheless, the UK  has given at least one dose of a coronavirus vaccine to roughly 50% of the population, which brought sharply down the number of daily deaths and contagions.

The UK will publish on Friday Halifax House Prices for the three months to March, while the BOE will publish its Quarterly Bulletin for the first quarter of the year.

GBP/USD short-term technical outlook

The GBP/USD pair is still at risk of falling according to intraday technical readings. The 4-hour chart shows that it keeps developing below all of its moving averages, with the 20 SMA accelerating south and about to cross below the 100 SMA, both around the 1.3815 level. The Momentum indicator bounced from daily lows but lost strength upward within negative levels, while the RSI indicator is stable around 38, indicating a lack of buying interest. A steeper decline is on the table on a break below 1.3720, the immediate support level.

 Support levels: 1.3720 1.3680 1.3640

Resistance levels: 1.3770 1.3810 1.3865  

View Live Chart for the GBP/USD

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Latest Forex Analysis

Latest Forex Analysis

Editors’ Picks

EUR/USD consolidates above 1.2000 as USD bulls take a breather

EUR/USD is in downside consolidation above 1.2000 amid risk-off mood. The US dollar clings to overnight recovery gains while the yields steady. J&J’s covid vaccine news fails to cheer the euro amid rising infections globally.


GBP/USD remains pressured below 1.3950 amid mixed UK data

GBP/USD holds lower ground below 1.3950, extending the pullback from seven-week highs. The US dollar’s strength, Brexit jitters and covid woes supersede the upbeat UK jobs data and re-opening optimism. UK CPI misses estimates with 0.7% in March.


Gold likely to face stiff resistance near $1795-$1800, focus on yields

Gold (XAU/USD) rebounded on Tuesday as the US Treasury yields tumbled alongside global stocks. Surging covid infections globally brought a reality check into the markets and triggered a fresh risk-aversion wave.

Gold News

ETH price eyes all-time highs as ETFs receive approval in Canada

Canada’s Ontario Securities Commission approved three Ethereum ETFs on April 20. This move comes after the recently launched Bitcoin ETF surpassed $1 billion in AUM. Ethereum price looks to surge 15% to retest recently set up highs around $2,548.

Read more

Markets tumble as covid fears overshadow vaccination drive

European markets have been hit hard, with rising global Covid cases serving as a reminder of how mutations could derail the recovery. Meanwhile, improved jobs data has helped the pound, but comes to the detriment of the FTSE 100. 

Read more